Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?
European Journal of Vascular and Endovascular Surgery · 2023
DOI: 10.1016/j.ejvs.2023.05.012 ↗Kurz gefasst
Kommentar in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2023. Verfasst von Willemien van de Water und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: Willemien.van…. Hauptthemen laut MEDLINE: Vascular Diseases, Peripheral Arterial Disease. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Vascular and Endovascular Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: Willemien.van.de.water@mumc.nl.
- Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.
Zitieren
APA
van de Water, W., & Siegerink, B. (2023). Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2023.05.012
Vancouver
van de Water W, Siegerink B. Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?. European Journal of Vascular and Endovascular Surgery. 2023. doi:10.1016/j.ejvs.2023.05.012
BibTeX
@article{vandeWater2023,
author = {van de Water, Willemien and Siegerink, Bob},
title = {Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2023},
doi = {10.1016/j.ejvs.2023.05.012}
}
EUVIMED